tirzepatide the best selling medication Eli Lilly's weight loss, diabetes drug tops Keytruda as world's best-selling medicine changing treatment that can accelerate your weight loss journey and help you achieve lasting results. The Top 10 Best-Selling Drugs

Some providers start patients at 5 mg if they tolerated high-dose semaglutide without significant side effects

Our analysis represents patients who had these data available

Understanding these indirect mechanisms is crucial for patients and healthcare professionals when evaluating menstrual changes during tirzepatide therapy

Do not double up if you miss a dose

A systematic review specifically examining tirzepatide found no significantly increased risk of pancreatitis compared to control groups including placebo, basal insulin, and selective GLP-1 receptor agonists

An abstract reporting part of the results presented here was submitted to the Endocrine Societys annual meeting ENDO 2025 (12 July 2025 to 15 July 2025, San Francisco, CA, USA)